Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):389-420.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Drug Resistance, Viral
  • Guanine / analogs & derivatives
  • Guanine / therapeutic use
  • HIV Infections / complications
  • Hepatitis B Vaccines
  • Hepatitis B e Antigens / analysis
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / diagnosis
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / prevention & control
  • Hepatitis B, Chronic / transmission
  • Hepatitis C, Chronic / complications
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Lamivudine / therapeutic use
  • Liver Cirrhosis / surgery
  • Liver Cirrhosis / virology
  • Liver Transplantation
  • Mass Screening
  • Nucleosides / therapeutic use
  • Organophosphonates / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Pyrimidinones / therapeutic use
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Telbivudine
  • Thymidine / analogs & derivatives
  • Vaccination

Substances

  • Antiviral Agents
  • Hepatitis B Vaccines
  • Hepatitis B e Antigens
  • Interferon alpha-2
  • Interferon-alpha
  • Nucleosides
  • Organophosphonates
  • Pyrimidinones
  • Recombinant Proteins
  • Reverse Transcriptase Inhibitors
  • Telbivudine
  • Lamivudine
  • Polyethylene Glycols
  • entecavir
  • Guanine
  • adefovir
  • Adenine
  • peginterferon alfa-2a
  • Thymidine